Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers

被引:122
作者
Ishihara, Tsutomu [1 ,2 ]
Maeda, Taishi [1 ]
Sakamoto, Haruka [1 ]
Takasaki, Naoko [1 ]
Shigyo, Masao [1 ]
Ishida, Tatsuhiro [3 ]
Kiwada, Hiroshi [3 ]
Mizushima, Yutaka [4 ]
Mizushima, Tohru [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 862, Japan
[2] Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 963, Japan
[3] Univ Tokushima, Inst Hlth Biosci, Tokushima 770, Japan
[4] Jikei Univ Sch Med, DDS Inst, Tokyo 105, Japan
基金
日本科学技术振兴机构;
关键词
PEGYLATED LIPOSOMES; REPEATED INJECTION; IN-VIVO; BIODEGRADABLE NANOPARTICLES; THERAPEUTICS; RATS; ENCAPSULATION; COPOLYMERS; CANCER;
D O I
10.1021/bm100754e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The accelerated blood clearance (ABC) phenomenon is induced upon repeated injections of poly(ethylene glycol) (PEG)-coated colloidal carriers. It is essential to suppress this phenomenon in a clinical setting because the pharmocokinetics must be reproducible. In this study, we evaluated the induction of the ABC phenomenon using nanoparticles coated with various hydrophilic polymers instead of PEG. Nanoparticles encapsulating prostaglandin El were prepared by the solvent diffusion method from a blend of poly(lactic acid) (PEA) and block copolymers consisting of various hydrophilic polymers and PLA. Coating of nanoparticles with poly(N-vinyl-2-pyrrolidone) (PVP), poly(4-acryloylmorpholine), or poly(N,N-dimethylocrylamide) led to extended residence of the nanoparticles in blood circulation in rats, although they had a shorter half-life than the PEG-coated nanoparticles. The ABC phenomenon was not induced upon repeated injection of PVP-coated nanoparticles at various time intervals, dosages, or frequencies, whereas it was elicited by PEG-coated nanoparticles. In addition, anti-PVP IgM antibody, which is estimated to be one of the crucial factors for induction of the ABC phenomenon, was not produced after injection of PVP-coated nanoparticles. These results suggest that the use Of PVP, instead of PPG, as m coating material for colloidal carriers Can evade the ABC phenomenon.
引用
收藏
页码:2700 / 2706
页数:7
相关论文
共 43 条
[1]  
Dams ETM, 2000, J PHARMACOL EXP THER, V292, P1071
[2]   Nanoparticle therapeutics: an emerging treatment modality for cancer [J].
Davis, Mark E. ;
Chen, Zhuo ;
Shin, Dong M. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :771-782
[3]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[4]  
ESUMI Y, 1986, CLIN REPORT, V20, P4399
[5]   Twice-weekly administration of peginterferon-α-2b improves viral kinetics in patients with chronic hepatitis C genotype 1 [J].
Formann, E ;
Jessner, W ;
Bennett, L ;
Ferenci, P .
JOURNAL OF VIRAL HEPATITIS, 2003, 10 (04) :271-276
[6]   Effect of Poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as Coating Agent on the Opsonization, Phagocytosis, and Pharmacokinetics of Biodegradable Nanoparticles [J].
Gaucher, Genevieve ;
Asahina, Kinji ;
Wang, Jiaohong ;
Leroux, Jean-Christophe .
BIOMACROMOLECULES, 2009, 10 (02) :408-416
[7]   METABOLISM OF PROSTAGLANDINS-A1 AND PROSTAGLANDINS-E1 IN MAN [J].
GOLUB, M ;
ZIA, P ;
MATSUNO, M ;
HORTON, R .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (06) :1404-1410
[8]   Polymer therapeutics: Concepts and applications [J].
Haag, R ;
Kratz, F .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (08) :1198-1215
[9]   Pharmacokinetic consequences of pegylation [J].
Hamidi, Mehrdad ;
Azadi, Amir ;
Rafiei, Pedram .
DRUG DELIVERY, 2006, 13 (06) :399-409
[10]   Effect of pegylation on pharmaceuticals [J].
Harris, JM ;
Chess, RB .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) :214-221